MGMT and glioblastoma: Multiple large‐scale clinical studies proved that GBM patients with O6‐methylguanine‐DNA methyltransferase (MGMT) promoter hypermethylation benefit from alkylating agent therapy, especially temozolomide (TMZ).4, 5, 6, 7